# PREMIX vs PREMED Intranasal Lidocaine and Midazolam

> **NCT03054844** · PHASE2 · COMPLETED · sponsor: **Columbia University** · enrollment: 55 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Lidocaine
- **DRUG:** Lidocaine and midazolam (PREMIX)
- **DRUG:** Midazolam

## Key facts

- **NCT ID:** NCT03054844
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-03
- **Primary completion:** 2017-10-10
- **Final completion:** 2017-10-10
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2019-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03054844

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03054844, "PREMIX vs PREMED Intranasal Lidocaine and Midazolam". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03054844. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*